We're thrilled to announce that the results of our survey conducted amongst 197 oncology nurses in the USA have been published in the journal Healthcare and also presented as a poster at the Oncology Nursing Society meeting (April 10-14 2025). Listen to co-author Natasha Pinheiro as she explains the rationale for the survey and discusses key results.

We're thrilled to announce that the results of our survey conducted amongst 197 oncology nurses in the USA have been published in the journal Healthcare and also presented as a poster at the Oncology Nursing Society meeting (April 10-14 2025). Listen to co-author Natasha Pinheiro as she explains the rationale for the survey and discusses key results.

Access the paper online here: The Evolving Role of the Oncology Nurse in the United States of America.  

The survey results highlight: 

  • How roles and responsibilities of cancer nurses have evolved since the COVID-19 pandemic and how their workload has increased
  • The importance of self-care initiatives and education to support nurses in their complex, busy and emotionally charged work environment, and to help retain existing nurses and attract new ones

Read the publication to gain insights into this important role.  Download the slide kit and poster for a summary of the results.  

 

Clinical takeaways 

  • Oncology nurses' roles in the USA are expanding and evolving. Some changes have brought opportunities to improve patient care and make it more accessible  
  • There is a need to decrease the workload and emotional demands that are currently affecting nurses. They demand enhanced education and training 
  • Joint efforts from societies and institutions to work collaboratively and make existing education more accessible could improve this workforce’s current challenges 

Access the paper online here: The Evolving Role of the Oncology Nurse in the United States of America.  

The survey results highlight: 

  • How roles and responsibilities of cancer nurses have evolved since the COVID-19 pandemic and how their workload has increased
  • The importance of self-care initiatives and education to support nurses in their complex, busy and emotionally charged work environment, and to help retain existing nurses and attract new ones

Read the publication to gain insights into this important role.  Download the slide kit and poster for a summary of the results.  

 

Clinical takeaways 

  • Oncology nurses' roles in the USA are expanding and evolving. Some changes have brought opportunities to improve patient care and make it more accessible  
  • There is a need to decrease the workload and emotional demands that are currently affecting nurses. They demand enhanced education and training 
  • Joint efforts from societies and institutions to work collaboratively and make existing education more accessible could improve this workforce’s current challenges 
Programme summary
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer.
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI NURSES CONNECT

GI NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved
Programme summary
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer.
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI NURSES CONNECT

GI NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

conference-update Conference update

Episode

2

of 2

episode
Oncology Rare diseases Endocrinology 
Actualités du Congrès l’ENETS 2026

Points de vue d’experts sur les dernières données concernant le cancer neuroendocrinien

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

Cette vidéo est soutenue par une subvention indépendante à visée éducative d’Ipsen.  Les contenus publiés sur ce site internet sont sous la responsabilité de leurs auteurs. Certaines données scientifiques publiées sur ce site sont susceptibles de ne pas être validées par la commission d’Autorisation de Mise sur le Marché, et ne doivent pas être mises en pratique. Elles doivent être lues et comprises avec le plus grand discernement et sont données dans leur cadre de la diffusion de l’information sur l’état actuel de la recherche auprès de la communauté scientifique internationale  
conference-update Conference update

Episode

1

of 2

episode
Oncology Rare diseases Endocrinology 
Update from ENETS 2026

Experts share their views on latest data in neuroendocrine cancer

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

This educational programme is supported by an Independent Educational Grant from Ipsen. The content published on this website is under the responsibility of its authors. Some scientific data published on this website may not have been validated by the relevant Marketing Authorisation Committees and should not be put into practice. It should be read and understood with the utmost discernment and is provided for the purpose of disseminating information on the current state of research to the international scientific community.
conference-update Conference update
Oncology 
Update from ESGO 2026 – PYNNACLE Phase 2 study: Interim results from the ovarian cancer cohort

Clinical insights and expert discussion

Experts
Prof. Domenica Lorusso, Prof. Jean-Sebastien Frenel
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Mar 2026

This programme has been sponsored by PMV Pharma and is intended for HCPs only.
publication Scientific Publication
Oncology 
ADCs in HER2+ metastatic breast cancer and management of adverse events

Consensus-based guidance for clinicians and patients

Experts
Prof. Javier Cortés, Prof. Giuseppe Curigliano, Prof. Shaheenah Dawood, Dr Grażyna Suchodolska, Dr Sara Tolaney, Carla Whitbread
Endorsed by
EONS - European Oncology Nursing Society Europa Donna
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Feb 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from AstraZeneca
expert-video-animation Animated Video
Oncology Obstetrics and Gynecology 
Understanding HER2 testing in gynecological cancers

Best practices and treatment implications

Experts
Prof. Fernando A. Soares
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative
  • download Downloadable
    Resources
  • clock 8 MIN
  • calendar Feb 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Daiichi Sankyo.